Követés
Tanya J Shaw
Tanya J Shaw
E-mail megerősítve itt: kcl.ac.uk
Cím
Hivatkozott rá
Hivatkozott rá
Év
Wound repair at a glance
TJ Shaw, P Martin
Journal of cell science 122 (18), 3209-3213, 2009
9622009
Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations
C Philippeos, SB Telerman, B Oulès, AO Pisco, TJ Shaw, R Elgueta, ...
Journal of Investigative Dermatology 138 (4), 811-825, 2018
3792018
Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring
R Mori, TJ Shaw, P Martin
The Journal of experimental medicine 205 (1), 43-51, 2008
3592008
Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer
TJ Shaw, MK Senterman, K Dawson, CA Crane, BC Vanderhyden
Molecular therapy 10 (6), 1032-1042, 2004
3172004
Wound repair: a showcase for cell plasticity and migration
TJ Shaw, P Martin
Current opinion in cell biology 42, 29-37, 2016
2262016
Epigenetic reprogramming during wound healing: loss of polycomb‐mediated silencing may enable upregulation of repair genes
T Shaw, P Martin
EMBO reports 10 (8), 881-886, 2009
1972009
Animal models of ovarian cancer
BC Vanderhyden, TJ Shaw, JF Ethier
Reproductive Biology and Endocrinology 1, 1-11, 2003
1852003
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study
RJ Schilder, MW Sill, RB Lee, TJ Shaw, MK Senterman, AJ Klein-Szanto, ...
Journal of clinical oncology 26 (20), 3418-3425, 2008
1362008
Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells
MD Steller, TJ Shaw, BC Vanderhyden, JF Ethier
Molecular cancer research 3 (1), 50-61, 2005
942005
Models of ovarian cancer—are we there yet?
K Garson, TJ Shaw, KV Clark, DS Yao, BC Vanderhyden
Molecular and cellular endocrinology 239 (1-2), 15-26, 2005
902005
Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo
TJ Shaw, EC Lacasse, JP Durkin, BC Vanderhyden
International journal of cancer 122 (6), 1430-1434, 2008
712008
Dissecting fibroblast heterogeneity in health and fibrotic disease
TJ Shaw, E Rognoni
Current rheumatology reports 22, 1-10, 2020
682020
Gene induction following wounding of wild‐type versus macrophage‐deficient Drosophila embryos
B Stramer, M Winfield, T Shaw, TH Millard, S Woolner, P Martin
EMBO reports 9 (5), 465-471, 2008
632008
Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression
TJ Shaw, EJ Keszthelyi, AM Tonary, M Cada, BC Vanderhyden
Experimental cell research 273 (1), 95-106, 2002
512002
Histone deacetylase 2 is upregulated in normal and keloid scars
EJF O'connor, II Badshah, LY Addae, P Kundasamy, S Thanabalasingam, ...
The Journal of investigative dermatology 132 (4), 1293, 2012
402012
AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate
TJ Shaw, BC Vanderhyden
Gynecologic oncology 105 (1), 122-131, 2007
372007
The biomechanical and histological sequelae of common skin banking methods
JMB Wood, M Soldin, TJ Shaw, M Szarko
Journal of Biomechanics 47 (5), 1215-1219, 2014
322014
Mechanisms of wound closure following acute arm injury in Octopus vulgaris
TJ Shaw, M Osborne, G Ponte, G Fiorito, PLR Andrews
Zoological letters 2, 1-10, 2016
302016
A workflow for rapid unbiased quantification of fibrillar feature alignment in biological images
S Marcotti, D Belo de Freitas, LD Troughton, FN Kenny, TJ Shaw, ...
Frontiers in computer science 3, 745831, 2021
272021
Metabolic perturbations in fibrosis disease
CY Ung, A Onoufriadis, M Parsons, JA McGrath, TJ Shaw
The International Journal of Biochemistry & Cell Biology 139, 106073, 2021
272021
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20